Healthcare - Biotechnology - NASDAQ - US
$ 1.8
-7.22 %
$ 53.4 M
Market Cap
-0.95
P/E
Price Target
Average
650.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
12.74%
Net Income
Estimate
9.14%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Immuneering Corporation
Wall Street analysts predict an average 1-year price target for IMRX of $13.5 , with forecasts ranging from a low of $3 to a high of $41 .
IMRX Lowest Price Target
Wall Street Target
3 USD
66.67%
IMRX Average Price Target
Wall Street Target
13.5 USD
650.00%
IMRX Highest Price Target
Wall Street Target
41 USD
2177.78%
REVENUE FORECAST
Revenue Forecast Chart IMRX
EBIT FORECAST
EBIT Forecast Chart IMRX
NET INCOME FORECAST
Net Income Chart IMRX